Trial intelligence / Profile preview

Pharmacologic modulation of fear memory consolidation in healthy volunteers

NL-OMON38140Not yet recruiting

Sponsor
Erasmus MC
Start
May 2012
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of atomoxetine, propranolol and Placebo-COD Research Private Ltd in post-traumatic stress disorder (PTSD), sponsored by Erasmus MC. Planned start May 2012; status: not yet recruiting.

02

Drugs

atomoxetinepropranololPlacebo-COD Research Private Ltd
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NL-OMON38140.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38140.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call